doi:10.3969/j.issn.1673-8640.2015.08.011

Abstract

CLC Number:

R446.62

Figures/Tables 4

References 9

[1]	LIANG X, BI S,YANG W, et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J]. Vaccine, 2009, 27(47): 6550-6557.
[2]	赵艳争. 4种方法测定低浓度HBsAg效果评价[J].河北联合大学学报:医学版,2014,16(1):58-59.
[3]	OLDE C, GARICIA M.Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen[J]. J Cannt, 1998, 8(4): 20-21.
[4]	平玲,魏园园,王家敏,等. 重组乙肝疫苗的研究进展[J].检验医学,2013,28(11):1055-1058.
[5]	崔富强,杨维中. 乙型肝炎疫苗预防接种与疑似不良反应[J].中华流行病学杂志,2014,35(1):1-2.
[6]	OTAGˇ F. False positive HBsAg result in blood donors due to administration of three different recombinant DNA hepatitis B vaccines[J].Vaccine, 2003, 21(25-26):3734-3737.
[7]	胡尧,刘维薇, 黄志基. 中和确认试验在电化学发光免疫法检测乙型肝炎表面抗原弱反应性中的价值探讨[J].检验医学,2013,28(3):218-220.
[8]	ANJUM Q.False positive hepatitis B surface antigen due to recent vaccination[J]. Int J Health Sci (Qassim), 2014, 8(2):189-193.
[9]	彭静,管青,王斌,等. HBsAg检测结果弱反应的分析与处置[J].临床检验杂志,2008,26(4):284-285.

观察组	HBsAg	抗HBs	HBeAg	抗HBe	抗HBc
初检	0.10±0.04	0.28(1.25)	0.36±0.06	1.90±0.27	0.08±0.03
复检	0.02±0.01^**	2.67(3.39)^*	0.37±0.05	1.95±0.19	0.07±0.03

观察组	HBsAg	抗HBs	HBeAg	抗HBe	抗HBc
初检	0.10±0.04	0.28(1.25)	0.36±0.06	1.90±0.27	0.08±0.03
复检	0.02±0.01^**	2.67(3.39)^*	0.37±0.05	1.95±0.19	0.07±0.03

组别	HBsAg	抗HBs	HBeAg	抗HBe	抗HBc
观察组	0.10±0.04	0.28(1.25)	0.36±0.06	1.90±0.27	0.08±0.03
对照组
模式1	0.03±0.01^**	1.43(2.64)^*	0.39±0.08	1.97±0.18	0.08±0.02
模式2	0.03±0.01^**	57.50(422.42)^**	0.37±0.12	1.92±0.22	0.07±0.02

组别	HBsAg	抗HBs	HBeAg	抗HBe	抗HBc
观察组	0.10±0.04	0.28(1.25)	0.36±0.06	1.90±0.27	0.08±0.03
对照组
模式1	0.03±0.01^**	1.43(2.64)^*	0.39±0.08	1.97±0.18	0.08±0.02
模式2	0.03±0.01^**	57.50(422.42)^**	0.37±0.12	1.92±0.22	0.07±0.02

[1]	TANG Qingqin, QIAO Longwei, YIN Jingping, ZHANG Sheng, FENG Bin, LIANG Yuting. Correlation of peripheral blood monocyte count and serum anti-phospholipase A2 receptor antibody in patients with nephrotic syndrome [J]. Laboratory Medicine, 2023, 38(7): 647-652.
[2]	WANG Haiping, LI He. BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis [J]. Laboratory Medicine, 2023, 38(7): 653-658.
[3]	WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493.
[4]	. [J]. Laboratory Medicine, 2023, 38(3): 291-293.
[5]	. [J]. Laboratory Medicine, 2023, 38(1): 100-102.
[6]	. [J]. Laboratory Medicine, 2022, 37(9): 892-893.
[7]	SUN Xiaodan, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Research progress on the role of estrogen receptor in osteosarcoma [J]. Laboratory Medicine, 2022, 37(4): 313-318.
[8]	SUN Xiaodan, XU Jing, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Inhibitory effects of antiestrogen on the proliferation and CCL2 expression of osteosarcoma cells [J]. Laboratory Medicine, 2022, 37(4): 319-324.
[9]	CHEN Si, LIU Hua, LIU Yiwen, HE Yiqing, ZHANG Guoliang, YANG Cuixia, DU Yan, GAO Feng. Clinical significance of combined determination of serum HER-2 and CD44 in colorectal cancer [J]. Laboratory Medicine, 2022, 37(4): 336-341.
[10]	ZHAO Mingna, ZHANG Chenzi, HONG Qiushuang, LOU Jiatao. Mechanism of IL-8/miR-182 positive feedback regulatory axis in non-small cell lung cancer [J]. Laboratory Medicine, 2022, 37(4): 349-355.
[11]	ZHANG Zhibin, YANG Wanyong, RUAN Fuwang, WEN Qinghui. Roles of total IgE,sIgE and 25（OH）D in the evaluation of infant atopic dermatitis [J]. Laboratory Medicine, 2022, 37(3): 217-220.
[12]	. [J]. Laboratory Medicine, 2021, 36(12): 1264-1266.
[13]	QIU Fang, ZHU Ping, JIANG Peng, WANG Chan. Relation between anti-gp210 antibody,anti-sp100 antibody and ALBI score in patients with primary biliary cholangitis [J]. Laboratory Medicine, 2021, 36(11): 1106-1109.
[14]	. [J]. Laboratory Medicine, 2021, 36(9): 925-928.
[15]	LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg [J]. Laboratory Medicine, 2020, 35(10): 1056-1061.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 9

Related Articles 15

Recommended Articles

Metrics